CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause value decay over time, so holding CURE for months or years leads to underperformance versus the underlying index. CURE is effective for tactical trades or hedges on short-term healthcare sector moves, but not for buy-and-hold strategies.
Sometimes traders can set up a potential plays when they see where investor money is flowing. This is available with fund inflows, which saw technology and healthcare equities gain a lion's share of February's flows.
We highlight a bunch of the best-performing leveraged equity ETFs halfway through the first quarter.
![]() CURE 7 months ago Paid | Quarterly | $0.12 Per Share |
![]() CURE 10 months ago Paid | Quarterly | $0.33 Per Share |
![]() CURE 25 Jun 2024 Paid | Quarterly | $0.27 Per Share |
![]() CURE 19 Mar 2024 Paid | Quarterly | $0.35 Per Share |
![]() CURE 21 Dec 2023 Paid | Quarterly | $0.57 Per Share |
![]() CURE 7 months ago Paid | Quarterly | $0.12 Per Share |
![]() CURE 10 months ago Paid | Quarterly | $0.33 Per Share |
![]() CURE 25 Jun 2024 Paid | Quarterly | $0.27 Per Share |
![]() CURE 19 Mar 2024 Paid | Quarterly | $0.35 Per Share |
![]() CURE 21 Dec 2023 Paid | Quarterly | $0.57 Per Share |
XBER Exchange | US Country |
This fund is designed for investors seeking aggressive investment exposure to the healthcare sector. By committing at least 80% of its net assets to financial instruments that offer 3X daily leveraged exposure to a specific index, the fund aims to amplify the returns of its underlying index on a day-to-day basis. The index in question is comprised of domestic companies operating within the healthcare sector. This includes a broad range of industries from pharmaceuticals and biotechnology to health care equipment, providers, and services. The fund's strategy is characterized by its non-diversified nature, focusing on maximizing the leveraged returns from this specific sector. It's crucial for potential investors to understand the inherent risks and rewards associated with leveraging, as it significantly magnifies both gains and losses depending on the daily index performance.
This product is the cornerstone of the fund, aiming to triple the daily performance of its healthcare sector index. It's achieved through leveraging, a technique that uses financial instruments like futures and options to increase potential returns. Intended for experienced investors who are comfortable with high risk for the chance of high reward, this aggressive strategy highlights the fund's focus on capitalizing on short-term movements within the healthcare sector.
The fund targets an array of industries within the healthcare sector, ensuring a focused yet comprehensive coverage. This includes investments in:
This diversified approach within the healthcare sector itself allows the fund to capitalize on various growth opportunities, from established pharmaceutical giants to emerging biotech innovators.